Swasti Vinayaka Synthetics Sets Q2 FY27 Results Review
Key highlights
- Swasti Vinayaka Synthetics will hold its Q2 FY27 results board meeting on November 13, 2026.
- The board will consider unaudited results for the quarter and half year ended September 30, 2026.
- Q1 FY27 sales were ₹7.22 crore, down 2.6% year-on-year from ₹7.41 crore.
- Q1 FY27 net profit rose 120% year-on-year to ₹0.55 crore from ₹0.25 crore.
powered by IRIS

Swasti Vinayaka Synthetics Limited will consider and approve its unaudited Q2 FY27 and half-year financial results on November 13, 2026, after reporting Q1 FY27 sales of ₹7.22 crore, down 2.6% year-on-year, while net profit rose 120% to ₹0.55 crore.
Know Swasti Vinayaka Synthetics inside out
Results, valuation, peers and who's buying, in one view.
When will Swasti Vinayaka Synthetics review Q2 FY27 results?
Swasti Vinayaka Synthetics will hold its Board of Directors meeting on Friday, November 13, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026. The announcement places the company among listed businesses scheduled to report September-quarter performance during the ongoing results season.
The meeting is scheduled at the company's corporate office at 306, Tantia Jogani Industrial Estate, J. R. Boricha Marg, opposite Kasturba Hospital, Lower Parel, Mumbai 400 011. Along with the financial statements, the board will review the statutory auditor's Limited Review Report. The disclosure has been made under the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has not disclosed the expected revenue, profit, margin or any other performance metric for Q2 FY27 ahead of the board meeting. Therefore, the November 13 meeting is an approval and disclosure event, rather than a statement on the eventual financial outcome.
What will the board consider at the November 13 meeting?
The board will consider unaudited financial results for both the three months and six months ended September 30, 2026. This means the filing is expected to provide a comparison of the September quarter with prior periods as well as cumulative performance for the first half of FY27.
The Limited Review Report is a key part of the process for interim results. Swasti Vinayaka Synthetics stated that its statutory auditor's review will be placed before the board alongside the unaudited statements. For its Q1 FY27 results, the company had similarly said that the financial results were reviewed by the statutory auditors and approved by the board.
The September-quarter disclosure will follow the company's August 2026 publication of Q1 FY27 results. That earlier filing reported profit before tax of ₹0.729 crore and basic and diluted earnings per share of ₹0.06, compared with ₹0.03 in the quarter ended June 30, 2025.
How did Swasti Vinayaka Synthetics perform in Q1 FY27?
Swasti Vinayaka Synthetics reported Q1 FY27 sales of ₹7.22 crore, compared with ₹7.41 crore in Q1 FY26, a decline of 2.6%. Net profit for the June 2026 quarter was ₹0.55 crore, compared with ₹0.25 crore a year earlier, representing growth of 120%.
The June-quarter numbers followed a March 2026 quarter in which sales were ₹6.90 crore and net profit was ₹1.25 crore. The comparison shows that June-quarter sales improved sequentially, while profit was lower than the immediately preceding quarter. Operating profit was ₹0.94 crore in June 2026, against ₹2.38 crore in March 2026, and operating profit margin stood at 13.02%.
For the financial year ended March 31, 2026, the company reported total income of ₹33.87 crore, total expenses of ₹29.85 crore and profit before tax of ₹4.03 crore. Net profit from continuing operations was ₹3.05 crore, while earnings per share for the full year were ₹0.33.
Got a follow-up? Ask IRIS
Why do the September-quarter results matter for investors?
The Q2 FY27 results will show whether the Q1 pattern of lower sales and higher net profit continued into the September quarter. Since the company operates in suiting, shirting and apparel manufacturing, investors may assess reported revenue, operating expenses, operating margin and profitability for evidence of changes in business conditions.
The available quarterly record shows variation in sales and margins. Sales ranged from ₹6.90 crore in March 2026 to ₹10.63 crore in March 2025 across the reported periods, while operating profit margin ranged from negative 10.67% in September 2025 to 34.49% in March 2026. The forthcoming filing will add another data point to this record.
No share-price reaction, management guidance, dividend decision or operational change has been disclosed in the board-meeting intimation. Investors and market participants will need to rely on the approved financial statements and Limited Review Report once submitted to the exchange.
What is the recent financial and disclosure background?
Swasti Vinayaka Synthetics has made several results-related disclosures in 2026. It scheduled a board meeting on May 30, 2026, to consider audited results for the quarter and financial year ended March 31, 2026. The company subsequently resubmitted those audited results along with details required for determination of large corporate status for FY2025-26 after a communication from BSE.
The Q1 FY27 result was followed by a newspaper publication disclosure on August 17, 2026. The company also announced board appointments and re-appointments alongside its June-quarter results. These disclosures provide the immediate reporting context for the November 13 board meeting.
Swasti Vinayaka Synthetics is an India-based company engaged mainly in manufacturing suiting, shirting and apparel. Its Q2 FY27 announcement is relevant because it will provide the latest formal update on performance for the first half of the financial year.
Conclusion
Swasti Vinayaka Synthetics has scheduled a November 13, 2026 board meeting to approve Q2 FY27 and first-half unaudited results, together with the statutory auditor's Limited Review Report. The update follows Q1 FY27 sales of ₹7.22 crore and net profit of ₹0.55 crore, showing lower revenue but higher profit compared with the previous year.
The next item to watch is the exchange filing after the board meeting, particularly the reported September-quarter sales, operating margin, net profit and cumulative first-half figures. The company has not disclosed a financial target or outlook in the meeting intimation.


